Be 0 2 0 2 O
at 3 5 3 5 O
least 6 11 6 11 O
21 12 14 12 14 B-lower_bound
years 15 20 15 20 I-lower_bound
of 21 23 21 23 O
age 24 27 24 27 B-age

Be 0 2 28 30 O
scheduled 3 12 31 40 O
for 13 16 41 44 O
trans 17 22 45 50 B-treatment
- 22 23 50 51 I-treatment
jugular 23 30 51 58 I-treatment
liver 31 36 59 64 I-treatment
biopsy 37 43 65 71 I-treatment
the 44 47 72 75 O
day 48 51 76 79 O
of 52 54 80 82 O
the 55 58 83 86 O
ultrasound 59 69 87 97 O
procedure 70 79 98 107 O

Females 0 7 108 115 B-gender
who 8 11 116 119 O
are 12 15 120 123 O
pregnant 16 24 124 132 B-pregnancy
or 25 27 133 135 O
nursing 28 35 136 143 O

Patients 0 8 144 152 O
currently 9 18 153 162 O
on 19 21 163 165 O
chemotherapy 22 34 166 178 B-treatment
or 35 37 179 181 O
with 38 42 182 186 O
other 43 48 187 192 O
primary 49 56 193 200 O
cancers 57 64 201 208 B-cancer
requiring 65 74 209 218 O
systemic 75 83 219 227 B-treatment
or 84 86 228 230 I-treatment
hepatic 87 94 231 238 I-treatment
loco 95 99 239 243 I-treatment
- 99 100 243 244 I-treatment
regional 100 108 244 252 I-treatment
treatment 109 118 253 262 I-treatment

Patients 0 8 263 271 O
not 9 12 272 275 O
scheduled 13 22 276 285 O
for 23 26 286 289 O
trans 27 32 290 295 B-treatment
- 32 33 295 296 I-treatment
jugular 33 40 296 303 I-treatment
liver 41 46 304 309 I-treatment
biopsy 47 53 310 316 I-treatment

Patients 0 8 317 325 O
on 9 11 326 328 O
life 12 16 329 333 B-treatment
support 17 24 334 341 I-treatment
or 25 27 342 344 I-treatment
in 28 30 345 347 I-treatment
a 31 32 348 349 I-treatment
critical 33 41 350 358 I-treatment
care 42 46 359 363 I-treatment
unit 47 51 364 368 I-treatment

Patients 0 8 369 377 O
who 9 12 378 381 O
are 13 16 382 385 O
medically 17 26 386 395 O
unstable 27 35 396 404 O
, 35 36 404 405 O
patients 37 45 406 414 O
who 46 49 415 418 O
are 50 53 419 422 O
seriously 54 63 423 432 O
or 64 66 433 435 O
terminally 67 77 436 446 B-chronic_disease
ill 78 81 447 450 I-chronic_disease
, 81 82 450 451 O
and 83 86 452 455 O
patients 87 95 456 464 O
whose 96 101 465 470 O
clinical 102 110 471 479 O
course 111 117 480 486 O
is 118 120 487 489 O
unpredictable 121 134 490 503 O

Patients 0 8 504 512 O
who 9 12 513 516 O
have 13 17 517 521 O
received 18 26 522 530 O
an 27 29 531 533 O
investigational 30 45 534 549 B-treatment
drug 46 50 550 554 I-treatment
in 51 53 555 557 O
the 54 57 558 561 O
30 58 60 562 564 B-upper_bound
days 61 65 565 569 I-upper_bound
before 66 72 570 576 I-upper_bound
study 73 78 577 582 B-treatment
drug 79 83 583 587 I-treatment
administration 84 98 588 602 O
, 98 99 602 603 O
or 100 102 604 606 O
will 103 107 607 611 O
receive 108 115 612 619 O
one 116 119 620 623 O
within 120 126 624 630 O
72 127 129 631 633 B-upper_bound
h 130 131 634 635 I-upper_bound
afterwards 132 142 636 646 I-upper_bound

Patients 0 8 647 655 O
who 9 12 656 659 O
have 13 17 660 664 O
undergone 18 27 665 674 O
surgery 28 35 675 682 B-treatment
within 36 42 683 689 O
24 43 45 690 692 B-upper_bound
hours 46 51 693 698 I-upper_bound
prior 52 57 699 704 I-upper_bound
to 58 60 705 707 O
the 61 64 708 711 O
study 65 70 712 717 O
sonographic 71 82 718 729 O
examination 83 94 730 741 O

Patients 0 8 742 750 O
with 9 13 751 755 O
a 14 15 756 757 O
history 16 23 758 765 O
of 24 26 766 768 O
anaphylactic 27 39 769 781 B-chronic_disease
allergy 40 47 782 789 I-chronic_disease
to 48 50 790 792 O
eggs 51 55 793 797 B-allergy_name
or 56 58 798 800 O
egg 59 62 801 804 B-allergy_name
products 63 71 805 813 I-allergy_name
, 71 72 813 814 O
manifested 73 83 815 825 O
by 84 86 826 828 O
one 87 90 829 832 O
or 91 93 833 835 O
more 94 98 836 840 O
of 99 101 841 843 O
the 102 105 844 847 O
following 106 115 848 857 O
symptoms 116 124 858 866 O
: 124 125 866 867 O
generalized 126 137 868 879 O
urticaria 138 147 880 889 O
, 147 148 889 890 O
difficulty 149 159 891 901 O
in 160 162 902 904 O
breathing 163 172 905 914 O
, 172 173 914 915 O
swelling 174 182 916 924 O
of 183 185 925 927 O
the 186 189 928 931 O
mouth 190 195 932 937 O
and 196 199 938 941 O
throat 200 206 942 948 O
, 206 207 948 949 O
hypotension 208 219 950 961 O
, 219 220 961 962 O
or 221 223 963 965 O
shock 224 229 966 971 O
. 229 230 971 972 O
( 231 232 973 974 O
Subjects 232 240 974 982 O
with 241 245 983 987 O
nonanaphylactic 246 261 988 1003 B-chronic_disease
allergies 262 271 1004 1013 I-chronic_disease
to 272 274 1014 1016 O
eggs 275 279 1017 1021 O
or 280 282 1022 1024 O
egg 283 286 1025 1028 O
products 287 295 1029 1037 O
may 296 299 1038 1041 O
be 300 302 1042 1044 O
enrolled 303 311 1045 1053 O
in 312 314 1054 1056 O
the 315 318 1057 1060 O
study 319 324 1061 1066 O
, 324 325 1066 1067 O
but 326 329 1068 1071 O
must 330 334 1072 1076 O
be 335 337 1077 1079 O
watched 338 345 1080 1087 O
carefully 346 355 1088 1097 O
for 356 359 1098 1101 O
1 360 361 1102 1103 O
h 362 363 1104 1105 O
following 364 373 1106 1115 O
the 374 377 1116 1119 O
administration 378 392 1120 1134 O
of 393 395 1135 1137 O
SONAZOID 396 404 1138 1146 O
) 404 405 1146 1147 O

Patients 0 8 1148 1156 O
with 9 13 1157 1161 O
clinically 14 24 1162 1172 O
unstable 25 33 1173 1181 O
cardiac 34 41 1182 1189 B-chronic_disease
arrhythmias 42 53 1190 1201 I-chronic_disease
, 53 54 1201 1202 O
such 55 59 1203 1207 O
as 60 62 1208 1210 O
recurrent 63 72 1211 1220 O
ventricular 73 84 1221 1232 B-chronic_disease
tachycardia 85 96 1233 1244 I-chronic_disease

Patients 0 8 1245 1253 O
with 9 13 1254 1258 O
congenital 14 24 1259 1269 B-chronic_disease
heart 25 30 1270 1275 I-chronic_disease
defects 31 38 1276 1283 I-chronic_disease

Patients 0 8 1284 1292 O
with 9 13 1293 1297 O
pulmonary 14 23 1298 1307 B-chronic_disease
hypertension 24 36 1308 1320 I-chronic_disease
or 37 39 1321 1323 O
unstable 40 48 1324 1332 O
cardiopulmonary 49 64 1333 1348 B-chronic_disease
conditions 65 75 1349 1359 I-chronic_disease

Patients 0 8 1360 1368 O
with 9 13 1369 1373 O
recent 14 20 1374 1380 O
cerebral 21 29 1381 1389 B-chronic_disease
hemorrhage 30 40 1390 1400 I-chronic_disease

Patients 0 8 1401 1409 O
with 9 13 1410 1414 O
respiratory 14 25 1415 1426 B-chronic_disease
distress 26 34 1427 1435 I-chronic_disease
syndrome 35 43 1436 1444 I-chronic_disease

Patients 0 8 1445 1453 O
with 9 13 1454 1458 O
severe 14 20 1459 1465 O
emphysema 21 30 1466 1475 B-chronic_disease
, 30 31 1475 1476 O
pulmonary 32 41 1477 1486 B-chronic_disease
vasculitis 42 52 1487 1497 I-chronic_disease
, 52 53 1497 1498 O
or 54 56 1499 1501 O
a 57 58 1502 1503 O
history 59 66 1504 1511 O
of 67 69 1512 1514 O
pulmonary 70 79 1515 1524 B-chronic_disease
emboli 80 86 1525 1531 I-chronic_disease

Patients 0 8 1532 1540 O
with 9 13 1541 1545 O
thrombosis 14 24 1546 1556 B-chronic_disease
within 25 31 1557 1563 O
the 32 35 1564 1567 O
hepatic 36 43 1568 1575 O
, 43 44 1575 1576 O
portal 45 51 1577 1583 O
, 51 52 1583 1584 O
or 53 55 1585 1587 O
mesenteric 56 66 1588 1598 O
veins 67 72 1599 1604 O

Patients 0 8 1605 1613 O
with 9 13 1614 1618 O
uncontrolled 14 26 1619 1631 O
congestive 27 37 1632 1642 B-chronic_disease
heart 38 43 1643 1648 I-chronic_disease
failure 44 51 1649 1656 I-chronic_disease
( 52 53 1657 1658 O
NYHA 53 57 1658 1662 B-clinical_variable
Class 58 63 1663 1668 I-clinical_variable
IV 64 66 1669 1671 I-clinical_variable
) 66 67 1671 1672 O

Patients 0 8 1673 1681 O
with 9 13 1682 1686 O
unstable 14 22 1687 1695 O
occlusive 23 32 1696 1705 B-chronic_disease
disease 33 40 1706 1713 I-chronic_disease
( 41 42 1714 1715 O
e.g. 42 46 1715 1719 O
, 46 47 1719 1720 O
crescendo 48 57 1721 1730 B-chronic_disease
angina 58 64 1731 1737 I-chronic_disease
) 64 65 1737 1738 O

